Insufficient scRNA-seq data for expression of PGLYRP4 at single-cell level.
Insufficient scRNA-seq data for expression of PGLYRP4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 38% | 276.48 | 552 / 1445 | 64% | 9.85 | 117 / 183 |
tonsil | 0% | 0 | 0 / 0 | 91% | 8.65 | 41 / 45 |
skin | 72% | 974.39 | 1302 / 1809 | 10% | 1.17 | 46 / 472 |
lung | 1% | 1.97 | 5 / 578 | 57% | 5.44 | 661 / 1155 |
uterus | 1% | 30.93 | 2 / 170 | 56% | 6.87 | 256 / 459 |
bladder | 0% | 0 | 0 / 21 | 35% | 4.19 | 178 / 504 |
ovary | 0% | 0 | 0 / 180 | 20% | 0.62 | 85 / 430 |
pancreas | 0% | 0.65 | 1 / 328 | 17% | 0.63 | 31 / 178 |
intestine | 0% | 0.42 | 3 / 966 | 13% | 0.95 | 68 / 527 |
breast | 0% | 0 | 0 / 459 | 13% | 0.70 | 143 / 1118 |
stomach | 0% | 0 | 0 / 359 | 9% | 0.22 | 27 / 286 |
peripheral blood | 7% | 12.66 | 62 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
liver | 0% | 0 | 0 / 226 | 2% | 0.06 | 8 / 406 |
thymus | 0% | 0 | 0 / 653 | 2% | 0.04 | 10 / 605 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.01 | 4 / 502 |
adipose | 0% | 1.37 | 6 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.02 | 2 / 901 |
muscle | 0% | 0.20 | 1 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.38 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009253 | Biological process | peptidoglycan catabolic process |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0016045 | Biological process | detection of bacterium |
GO_0045087 | Biological process | innate immune response |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0008745 | Molecular function | N-acetylmuramoyl-L-alanine amidase activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016019 | Molecular function | peptidoglycan immune receptor activity |
Gene name | PGLYRP4 |
Protein name | Peptidoglycan recognition protein 4 (Peptidoglycan recognition protein I-beta) (PGLYRPIbeta) (PGRP-I-beta) (Peptidoglycan recognition protein intermediate beta) |
Synonyms | SBBI67 PGRPIB |
Description | FUNCTION: Pattern receptor that binds to murein peptidoglycans (PGN) of Gram-positive bacteria. Has bactericidal activity towards Gram-positive bacteria. May kill Gram-positive bacteria by interfering with peptidoglycan biosynthesis. Binds also to Gram-negative bacteria, and has bacteriostatic activity towards Gram-negative bacteria. Plays a role in innate immunity. . |
Accessions | Q96LB8 ENST00000359650.10 [Q96LB8-1] ENST00000368739.3 [Q96LB8-2] |